Success Stories: EB-1A and NIW Petitions Approved (Without RFE) for Postdoctoral Researcher in Pennsylvania with 143 Citations in the Field of Molecular Biology

Client’s Testimonial:

“It is such great news! Thank you so much for your help!!! […] You provided me lots of help during my I-140 case preparation and I really appreciate that!”

On June 28^th, 2016 and September 2^nd, 2016, we received another EB-1A (Alien of Extraordinary Ability) and EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Molecular Biology (Approval Notice).

General Field: Molecular Biology

Position at the Time of Case Filing: Postdoctoral Researcher

Country of Origin: China

Service Center: Nebraska Service Center (NSC)

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: June 28^th, 2016 (EB-1A) and September 2^nd, 2016 (EB-2 NIW)

Processing Time: 161 Days (EB-1A, Premium Processing Requested) and 263 Days (EB-2NIW)

Case Summary:

North America Immigration Law Group (WeGreened.com) filed two I-140 petitions on behalf of a postdoctoral researcher from China and to our delight, the USCIS approved both of them. We filed our client’s petitions under EB-1A (Alien of Extraordinary Ability) and EB-2 NIW (National Interest Waiver). Overall, the USICS spent 161 days adjudicating our client’s EB-1A petition and 263 days on her EB-2 NIW. It would have taken them far longer to process the former had she not chosen to upgrade her case to Premium Processing several months after filing (PP is a paid option that allows for action to be taken on I-140 petitions within 15 calendar days). We are especially pleased that neither of our client’s petitions were issued a Request for Evidence (RFE)—a testament to our diligent efforts in presenting our client’s credentials in a strong and persuasive manner.

Obtaining petition approval:

As an expert researcher in the field of molecular biology, our client had accomplished much throughout her illustrious career. Both petitions documented her Ph.D. in Biochemistry and Molecular Biology, the 143 citations gathered from her work, the 10 published articles to her name, and the 30 times she assessed the work of her peers for scientific periodicals. We also incorporated recommendation letters into her petition packets. These letters were volunteered by other influential molecular biologists, all of whom advocated for the approval of both petitions. This is what one of our client’s recommenders had to say about her: “The need for such a top-performing researcher as [Client] is truly immense, since the inflammatory and autoimmune diseases for which she is offering novel treatment solutions are so rampant.” Alongside these letters stood data on our client’s research projects on discovering the mechanisms behind the regulation of gene expression by transcription factors, in order to improve our understanding of fundamental biological processes such as nitrogen fixation and immune responses. We established that her work addresses some of the US’ most pressing issues in improving agricultural yields and treating conditions that originate at the molecular level, such as cancer and autoimmune diseases. Thankfully, the USCIS agreed with our argument that our client is an asset to the nation and approved both her EB-1A and EB-2 NIW petitions, propelling her one step closer to permanent residence.

The final step:

The final step in the complex green card process involves filing an I-485 application. Once the USCIS approves her application, she will officially become a proud green card holder. We wish our client the best with this step and thank her for choosing our law firm to represent both her I-140 petitions.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.